TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

INDIMIX

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

INDIMIX

ST13

US500000079350511

Classe

1, 5

Pedido

79350511

Registro

7646253

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

31

Atualização mais recente

02/08/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5

Data de depósito

21/06/2022

Data de registro

14/01/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

14/01/2025

Última transação

02/08/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

27

Localização do titular

DE

Examinador

MESSICK, TABITHA

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

INDICAL BIOSCIENCE GmbH

Representantes

Leo M. Loughlin Rothwell, Figg, Ernst & Manbeck, PC

Classificação técnica

Classes Nice

Classe 1Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemical, biochemical and biotechnological reagents for industrial and scientific purposes and laboratory analysis, other than in vivo use and other than for medical or veterinary purposes; Chemical, biochemical and biotechnological substances for industrial and scientific purposes and laboratory analysis, other than in vivo use and other than for medical or veterinary purposes; Biochemicals for scientific and research use, namely, for sample preparation, modification and manipulation of cells and for labeling, isolation, purification, amplification and analysis of natural and synthetic biopolymers in the nature of nucleotides, buffer substances such as salts and proteins for industrial use, macromolecules and biologically active substances, none of the foregoing for medical or veterinary use; biochemicals, namely, small molecular chemicals for scientific or research use; laboratory chemicals, namely, small molecular chemicals used for the detection of nucleic acids in cell and tissue analysis for in vitro diagnostic use; chemicals and biochemical preparations used in industry, in particular, chemical and biochemical substances for molecular biological, biochemical and immunological laboratory testing and analysis, other than for medical or veterinary purposes; kits comprising biochemical reagents for scientific and research use, namely, for sample preparation, modification and manipulation of samples and cells and for labeling, separation, isolation, purification, especially amplification and analysis of natural and synthetic biopolymers, in particular, nucleic acids for laboratory use, oligonucleotides, proteins for industrial use, macromolecules and biologically active substances, none of the foregoing for medical or veterinary use; kits for multiplex polymerase chain reaction (PCR) tests comprised of DNA primers for amplifying DNA and RNA loci

Classe 5

Pharmaceutical medical preparations for treating infections; veterinary medical products, namely, vaccines; medical products for medical healthcare purposes, namely, reagents for medical use; diagnostic preparations for medical and veterinary purposes; diagnostic agents for medical and veterinary purposes, namely, diagnostic agents for medical and veterinary in-vitro diagnostics; diagnostic agents for medical and veterinary purposes, namely, biological diagnostic agents for testing diseases in cattle, pigs, and other animals; kits comprised of reagents for medical use, of antisense oligonucleotides being pharmaceutical preparations of monoclonal antibodies for use in disease testing, and of in-vitro diagnostic reagents and diagnostic control reagents all for medical purposes, sold as a unit for medical purposes; diagnostic test kits comprised of testing equipment in the nature of biomolecules, namely, antisense oligonucleotides being pharmaceutical preparations, primers in the nature of nucleic acid sequences and probes in the nature of single stranded sequences for DNA and RNA biomarker testing and DNA and RNA infectious disease testing for medical, veterinary, and dental purposes; products for medical and veterinary medical purposes, namely, diagnostic preparations for sample preparation, for modification and manipulation of cells and for labelling, for separation, for isolation, for purification, for amplification and for analysis of natural and synthetic biopolymers, in the nature of nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances all being diagnostic medical preparations; chemical, biochemical and biotechnological products, namely, reagents for medical use, for sample preparation, and for modification and manipulation of cells, all for medical use; in vitro diagnostic preparations for medical purposes; diagnostic disease testing kits comprised of medical diagnostic reagents; buffers for medical and veterinary purposes, namely, extraction buffers; diagnostic disease testing kits comprised of chemical reagents for medical use, antisense oligonucleotides being pharmaceutical preparations, nucleotides being pharmaceutical preparations, extraction buffers, in-vitro diagnostic preparations, and diagnostic control reagents, all for medical and veterinary use, sold as a unit for medical and veterinary use

Publicações

Histórico de despachos e eventos da marca no USPTO.

31 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

01/08/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

11/07/2025

FIMP

FINAL DISPOSITION PROCESSED

11/07/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

14/04/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

14/01/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

14/01/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

17/09/2024

PUBO

PUBLISHED FOR OPPOSITION

17/09/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

28/08/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/08/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/07/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/07/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/07/2024

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

18/03/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

28/02/2024

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

28/02/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/01/2024

GNRT

NON-FINAL ACTION E-MAILED

09/01/2024

CNRT

NON-FINAL ACTION WRITTEN

09/01/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/12/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/12/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/12/2023

RFNT

REFUSAL PROCESSED BY IB

26/06/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/06/2023

RFRR

REFUSAL PROCESSED BY MPU

06/06/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/04/2023

CNRT

NON-FINAL ACTION WRITTEN

08/04/2023

DOCK

ASSIGNED TO EXAMINER

01/04/2023

MAFR

APPLICATION FILING RECEIPT MAILED

27/09/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

23/09/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

22/09/2022

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace INDIMIX ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.